News Focus
News Focus
Followers 38
Posts 1153
Boards Moderated 0
Alias Born 03/20/2013

Re: highwayman4life post# 431356

Sunday, 01/02/2022 9:52:01 PM

Sunday, January 02, 2022 9:52:01 PM

Post# of 817895
Great post highwayman, the Data from the DCVax trial tells us that some patients have been cured of GBM with DCVax treatment. Currently there is no commercial treatment on the market that can cure GBM. NWBO holds the IP and patents on a treatment that has cured people with GBM and has results to prove it. This is a big deal folks!!! Here is an article published last year on survival, it's a great read!!! Here is the conclusion

Overall estimates of survival among patients with glioblastoma have at least doubled since 2005 to 18% at 2 years and 11% at 3 years. This may reflect treatment response to modern therapeutic approaches. However, longer term survival remains poor and there appears to be a lack of improvement in 5-year survival. Large population-based studies with detailed clinical characteristics would clarify whether there has been an increase in the use of multimodal therapy and whether multimodal therapy affects survival beyond 5 years. Differences in msolecular markers of tumour subtypes may shed light on the underlying disease mechanisms that influence survival.

https://www.nature.com/articles/s41598-020-68011-4
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News